Sivers Semiconductors AB (publ) (SIVEF) Q1 2026 Earnings Call Transcript

Sivers Semiconductors reported Q1 2026 revenue of SEK 61.9 million, or about SEK 70 million on a constant-currency basis, with adjusted EBITDA of negative SEK 13.8 million. Management said the opportunity pipeline has expanded to just under $800 million as of May, but near-term U.S. government shutdown-related defense spending delays and FX headwinds are weighing on the first half of 2026. Despite that, the company reaffirmed its 2026 annual revenue growth plans and said it is investing in sales and U.S. dual-listing readiness.

Analysis

The key signal here is not the near-term revenue print, but the step-change in the qualified demand pipeline. For a subscale semiconductor/fragments business, a move toward a much larger forward funnel typically matters more than one quarter’s revenue noise because it improves financing optionality, pricing power, and the probability of crossing fixed-cost absorption thresholds over the next 4-8 quarters. The market is likely underappreciating that defense-related design wins tend to be lumpy but sticky once integrated, which can create a non-linear re-rating when shipments start rather than when the pipeline is announced.

The FX drag is more important than it looks: if reported growth is being suppressed by currency while underlying activity is improving, consensus may anchor on a weaker first half and miss the setup for a cleaner second-half inflection. That said, the combination of sales-force investment and audit/pre-listing preparation implies margin pressure before any capital-markets benefit is realized; investors should expect operating leverage to lag commercial traction by several quarters. The dual-listing work is a governance catalyst, but it also raises execution risk if management attention gets split between go-to-market and listing readiness.

Second-order winners are likely to be the firms in the defense-electronics ecosystem with exposure to securing slots in constrained programs and those with stronger balance sheets that can outspend smaller competitors during the same demand window. The biggest loser is patience: this setup can look cheap for months before revenue conversion arrives, then re-rate abruptly once one or two contracts clear. The contrarian read is that the market may be too focused on headline profitability and too skeptical of the pipeline quality; for a company at this stage, the right question is not current EBITDA, but whether the company is building enough backlog density to outrun fixed overhead within a year.

Key Decisions for Investors

• Buy SIVEF on weakness over the next 2-6 weeks if the stock sells off on near-term margin compression; target a 6-12 month hold for pipeline conversion, with upside tied to evidence of backlog-to-revenue conversion rather than quarterly EBITDA alone.
• If liquid enough, pair long SIVEF / short a profitable defense-electronics peer with less pipeline growth over 3-9 months to isolate order-capture upside versus broader sector beta.
• Use call spreads rather than outright longs for a 6-9 month catalyst window around pipeline and dual-listing milestones; the optionality is asymmetric, but execution risk argues against paying full delta.
• Avoid shorting on the headline EBITDA miss alone; the better short would be a faded move only if the pipeline stops growing or if conversion slips for two consecutive quarters.
• Monitor for a second-half inflection in reported revenue ex-FX; if constant-currency growth starts showing through, add to longs because the market will likely re-rate before reported numbers fully catch up.